FatLiverDoc

@liverUSA So very sad for his family, such a terrible loss for the Chicago liver family and the hepatology community as well.

American Liver Foundation mourns the tragic loss of Josh Levitsky, MD, MS, FAST, FAASLD, a highly respected, devoted and patient-centric leader in the field of liver transplantation. liver.news/JLevitsky

@Rush_GI @ZoePostMD @aryannasousaMD @AASLDtweets @AASLDFoundation @NancyReau Amazing job by an amazing team with an amazing mentor!

So proud of our 3rd year fellow @ZoePostMD and transplant hepatology fellow @aryannasousaMD on their excellent presentations/arguments for the academic debate at The Liver Meeting! Great job! 👏🏻🤩 #TLM24 @AASLDtweets @AASLDFoundation

Have you ever wondered ... how beta-blockers treat #cirrhosis? Here's a #tweetorial featuring: 1⃣Pathophys! 2⃣controversy! 3⃣Cheap, life-saving interventions! #livertwitter #gitwitter #meded 1/

MASLD: Promising Treatments for a Newly Renamed Disease medscape.com/viewarticle/99… via @medscape

@ALFGreatLakes Debates

All’s good at the @AlfDebates . Great debate on whether a mandatory lifestyle intervention should be instituted for patients being transplanted for NASH. Important and nuanced topic!

@gscottwinder I haven’t much time researching the actual assay to see how the values are calculated, but I believe there is a rough correlation although I am not sure it is a linear one. I say this based on my loose correlations between with level of reported etOH intake and PeTh level.

@gscottwinder Then I interpret the test like I was still a lab scientist... interpret the number in context, not the lab given cutoffs.

@gscottwinder I tell people the test I am running is not supposed to be positive with a single slip but rather from repeated chronic significant alcohol use. This is a way for them to know if the amount they are exposed to if any is too much. But tell them I believe them if they say it’s none.

@MikeAlbertMD A cornerstone of #obesitymedicine @OMAsocial @ObesitySociety @ObesityMedicine

Why therapeutic low-carb + HP is so effective in T2DM: Graph A: washout diet vs ADA diet (Carb 55%, Protein 15%, Fat 30%) Graph B: washout diet vs therapeutic low-carb + HP (Carb 20%, Protein 30%, Fat 50%) *Glycemic control is superior with low-carb (non-keto) + high protein*

@AtoosaRabiee @rrosenblattmd @BloomPringle @ebtapper @AutoImmuneLiver @serperm @DrLiver Sarcoid with normal alk phos?.... suspicious.

#Livertwitter - pt with hepatic sarcoidosis, AST/ALT 80/160, no active disease elsewhere, what do you offer for treatment? (Pt refuses steroids, didn’t help when she got them, I’ll review osh bx @BloomPringle @ebtapper @AutoImmuneLiver @serperm @DrLiver

@AtoosaRabiee @SultanMahmoodMD @GiJournal @MaureenWhitsett @liverazzi @ebtapper @ArpanPatelMD @JBenhammouMD @BloomPringle @JonathanStineMD @gnioannou @drkeithsiau @Will_Sanchez_MD @BWSadowskiMD @SanchezLunaMD @AhmadBazarbashi completely agree. you just said it better :) twitter.com/LiverFat/statu…

Its time for another exciting JC discussion. Here is a quick summary of the article

@AtoosaRabiee @SultanMahmoodMD @GiJournal @MaureenWhitsett @liverazzi @ebtapper @ArpanPatelMD @JBenhammouMD @BloomPringle @JonathanStineMD @gnioannou @drkeithsiau @Will_Sanchez_MD @BWSadowskiMD @SanchezLunaMD @AhmadBazarbashi agreed, I think that once you have HRS and are likely on chronic midodrine therapy, NSBB are out. but agreed, maybe this is another clinical characteristic (with SBP, refractory ascites) that should lead to hold BB. but again, need mortality data.

@AtoosaRabiee agreed, but in the end, this study just shows that as they get sicker, they are more likely to get cirrhotic cardiomyopathy. The "new" (quotes intentional) thing was that cirrhotic cardiomyopathy predicts HRS. but like you said.. does it change ur mgmt.

@MTPapaD @AtoosaRabiee @ZeeshanAKhanMD @SultanMahmoodMD @GiJournal @mqkMD @ijlalakbar @DrMohdZein @GI_Pearls @LiverToronto @NAFLDSupport @LizzieAbyMD @stevenbollipo @ZainAsadEP Ha. yes, but that being said, say "ANSWER" study, and you know it. Ask which hep C study was the CORAL study? probably not a fair comparison as there are not 10,000 albumin studies in the past decade.

@AtoosaRabiee @MTPapaD @ZeeshanAKhanMD @SultanMahmoodMD @GiJournal @mqkMD @ijlalakbar @DrMohdZein @GI_Pearls @LiverToronto @NAFLDSupport @LizzieAbyMD @stevenbollipo @ZainAsadEP ANSWER was amazing, to find similar results in patients with refractory ascites was the icing on the cake. truly disease modifying therapy.

@AtoosaRabiee @MTPapaD @ZeeshanAKhanMD @SultanMahmoodMD @GiJournal @mqkMD @ijlalakbar @DrMohdZein @GI_Pearls @LiverToronto @NAFLDSupport @LizzieAbyMD @stevenbollipo @ZainAsadEP shoot. I just realized that question may have been for the trainees. SORRY!

@AtoosaRabiee @MTPapaD @ZeeshanAKhanMD @SultanMahmoodMD @GiJournal @mqkMD @ijlalakbar @DrMohdZein @GI_Pearls @LiverToronto @NAFLDSupport @LizzieAbyMD @stevenbollipo @ZainAsadEP absolutely, in a study of patients with refractory ascites, outpatient albumin infusion reduced the incidence of HRS